Omega Funds

Chord Therapeutics SA is a biotechnology company based in Geneva, Switzerland, founded in 2014. It focuses on developing innovative drug therapies for rare and severely disabling diseases, specifically targeting conditions such as neuromyelitis optica spectrum disorders and myasthenia gravis. The company is advancing its lead drug candidate, CRD1, which has received orphan drug designation to address these critical health challenges. Chord Therapeutics is dedicated to repurposing small molecule drugs to provide effective treatments that can significantly improve the quality of life for patients suffering from these rare neurological disorders.

Andrew Alliance is a Swiss robotics company that designs and commercializes automated liquid-handling solutions for the life sciences sector. The company offers a suite of hardware and software tools, including OneLab, a graphical interface to design liquid-handling workflows; Andrew+, a pipetting robot compatible with conventional electronic pipettes; Pipette, a cloud-enabled device to improve ergonomics and traceability; and Andrew, a portable liquid-handling robot that can operate unattended with manual pipettes. It also provides Andrew Assistant, a protocol-design software to create, verify, and document biology protocols that require quantitative liquid handling. Products are assembled and tested in Switzerland, with service and support based in Geneva and an office in Boston, and are sold directly and through distributor partners internationally. Founded in 2011, Andrew Alliance is an independent Swiss company that combines robotics, vision and software to enable researchers to perform precise, repeatable liquid-handling operations more efficiently, aiming to enhance accuracy and throughput in laboratory workflows.

Andrew Alliance is a Swiss robotics company that designs and commercializes automated liquid-handling solutions for the life sciences sector. The company offers a suite of hardware and software tools, including OneLab, a graphical interface to design liquid-handling workflows; Andrew+, a pipetting robot compatible with conventional electronic pipettes; Pipette, a cloud-enabled device to improve ergonomics and traceability; and Andrew, a portable liquid-handling robot that can operate unattended with manual pipettes. It also provides Andrew Assistant, a protocol-design software to create, verify, and document biology protocols that require quantitative liquid handling. Products are assembled and tested in Switzerland, with service and support based in Geneva and an office in Boston, and are sold directly and through distributor partners internationally. Founded in 2011, Andrew Alliance is an independent Swiss company that combines robotics, vision and software to enable researchers to perform precise, repeatable liquid-handling operations more efficiently, aiming to enhance accuracy and throughput in laboratory workflows.